Literature DB >> 10472213

Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related.

C Sirtl1, H Laubenthal, V Zumtobel, D Kraft, W Jurecka.   

Abstract

Tissue deposits occur after administration of plasma substitutes. After hydroxyethyl starch (HES), deposits may last for months, causing pruritus and impairment of function. Because elimination of HES deposits has not been demonstrated in humans, we studied 26 patients, for up to 7 yr after HES administration, to assess HES storage. HES dose ranged from 0.34 to 15.00 g kg-1 body weight, and administration intervals from 1 day to 7 yr. Biopsies of the liver, muscle, spleen, intestine or skin were studied using light and electron microscopy and immunohistochemistry. HES storage was dose-dependent, decreased in all organs with time and was greater in patients suffering from pruritus. We conclude that tissue deposition of HES is transitory and dose-dependent, with differences between subjects in severity and duration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10472213     DOI: 10.1093/bja/82.4.510

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  19 in total

Review 1.  Pharmacokinetics of hydroxyethyl starch.

Authors:  Cornelius Jungheinrich; Thomas A Neff
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Pharmacodynamics and organ storage of hydroxyethyl starch in acute hemodilution in pigs: influence of molecular weight and degree of substitution.

Authors:  Christoph Eisenbach; Alexander H Schönfeld; Norbert Vogt; Moritz N Wente; Jens Encke; Wolfgang Stremmel; Eike Martin; Ernst Pfenninger; Markus A Weigand
Journal:  Intensive Care Med       Date:  2007-06-07       Impact factor: 17.440

3.  Hydroxy-ethyl-starches: are the conclusions always evidence-based?

Authors:  Georges Mion; Nicolas Libert; Audrey Cirodde
Journal:  Intensive Care Med       Date:  2009-02-17       Impact factor: 17.440

Review 4.  Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis.

Authors:  Amit Patel; Umeer Waheed; Stephen J Brett
Journal:  Intensive Care Med       Date:  2013-02-22       Impact factor: 17.440

5.  Clinical use of hydroxyethyl starch and serious adverse effects: Need for awareness amongst the medical fraternity.

Authors:  Sushil Kumar
Journal:  Med J Armed Forces India       Date:  2014-07

Review 6.  Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies.

Authors:  Romuald Bellmann; Clemens Feistritzer; Christian J Wiedermann
Journal:  Clin Pharmacokinet       Date:  2012-04-01       Impact factor: 6.447

7.  Are all colloids same? How to select the right colloid?

Authors:  Sukanya Mitra; Purva Khandelwal
Journal:  Indian J Anaesth       Date:  2009-10

8.  [Hydroxyethyl starch-(HES)-induced pruritus as secondary complication of an occupational accident].

Authors:  E Weisshaar; S Ständer; D Metze; T L Diepgen
Journal:  Hautarzt       Date:  2004-06       Impact factor: 0.751

9.  The impact of crystalloid and colloid infusion on the kidney in rodent sepsis.

Authors:  Martin Alexander Schick; Tobias Jobst Isbary; Nicolas Schlegel; Juergen Brugger; Jens Waschke; Ralf Muellenbach; Norbert Roewer; Christian Wunder
Journal:  Intensive Care Med       Date:  2009-11-05       Impact factor: 17.440

Review 10.  Choosing a volume expander in critical care medicine.

Authors:  Niranjan Kissoon; Desmond Bohn
Journal:  Indian J Pediatr       Date:  2003-12       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.